This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

14 Dec 2011

Vanda Pharmaceuticals Inks License Deal with Israel's Megapharm

Vanda Pharmaceuticals announced exclusive license agreement with Megapharm for the commercialization of Fanapt? in Israel.

U.S. biopharmaceutical company Vanda Pharmaceuticals announced yesterday its exclusive license agreement with Megapharm Ltd., one of Israel's leading private biotech, pharmaceutical and medical nutrition marketing companies, for the commercialization of Fanapt?  in Israel.


Under the terms of the agreement, Megapharm will seek regulatory approval for Fanapt?  in Israel. Vanda will supply Megapharm with Fanapt?  drug product for packaging and sale and Megapharm's CNS specialty sales force will promote Fanapt? to psychiatrists in Israel.


The application for regulatory approval of Fanapt? in Israel was filed in May 2011.




Related News